Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative mFOLFOX6 in Locally Advanced Gastric Cancer
NCT01851941Phase 2Completed
- Sponsor
- Seoul National University Hospital
- Start
- Oct 2004
- Primary completion
- Jun 2008
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of oxaliplatin and fluorouracil in gastric cancer (GC), sponsored by Seoul National University Hospital. Primary endpoint: Clinical Response Rate. Started Oct 2004; status: completed.
02
Drugs
oxaliplatinfluorouracil
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT01851941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01851941.